To further examine whether CCL24 expression is predictive of ccRCC patients’ prognosis, the ccRCC patients (n = 256) were first randomly divided into the training and validation cohorts at a 1:1 ratio. Here, CCL24 is linked to nonpapillary renal cell carcinoma.